Cargando…
Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer
Autores principales: | Lin, Zhuo-yuan, Chen, Guo, Zhang, Yan-qiong, He, Hui-chan, Liang, Yu-xiang, Ye, Jian-heng, Liang, Ying-ke, Mo, Ru-jun, Lu, Jian-ming, Zhuo, Yang-jia, Zheng, Yu, Jiang, Fu-neng, Han, Zhao-dong, Wu, Shu-lin, Zhong, Wei-de, Wu, Chin-Lee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683342/ https://www.ncbi.nlm.nih.gov/pubmed/31387585 http://dx.doi.org/10.1186/s12943-019-1051-x |
Ejemplares similares
-
MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer
por: Lin, Zhuo-yuan, et al.
Publicado: (2017) -
Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer
por: Lin, Zhuo-yuan, et al.
Publicado: (2023) -
Decreased Expression of MYPT1 Contributes to Tumor Angiogenesis and Poor Patient Prognosis in Human Prostate Cancer
por: Liang, Y., et al.
Publicado: (2018) -
MYPT1 reduction is a pathogenic factor of erectile dysfunction
por: Zhao, Wei, et al.
Publicado: (2022) -
Two faces of bivalent domain regulate VEGFA responsiveness and angiogenesis
por: Chen, Jiahuan, et al.
Publicado: (2020)